Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value in personalized vaccines.The prevailing theory has been that a therapy ...

The study shows lung and skin cancer patients who were undergoing a type of immunotherapy and who happened to get the COVID ...

Cancer vaccines have long sounded like science fiction, but a new wave of nanoparticle research is pushing that idea closer ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

Lung and skin cancer patients who were taking "checkpoint inhibitors" and had the COVID vaccine saw surprising results.